Edwards Lifesciences Depreciation Amortization and Accretion Trend

EW -- USA Stock  

USD 153.60  1.42  0.93%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Depreciation Amortization and Accretion of Edwards Lifesciences Corporation with missing and latest data points interpolated. A component of operating cash flow representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.
Depreciation Amortization and Accretion10 Years Trend
Increasing
Slightly volatile
 Depreciation Amortization and Accretion 
      Timeline 

Regression Statistics

Arithmetic Mean  62,038,866
Geometric Mean  61,692,094
Coefficient Of Variation  11.11
Mean Deviation  6,088,010
Median  58,700,000
Standard Deviation  6,893,093
Range  18,405,263
R Value  0.88
R Squared  0.77
Significance  0.00007715
Slope  1,555,119

Edwards Lifesciences Depreciation Amortization and Accretion Over Time

2016-12-31  71,200,000 
2017-12-31  71,200,000 
2018-12-31  72,105,263 

Other Fundumenentals

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Upcoming Events

Edwards Lifesciences Upcoming Company Events
Upcoming Quarterly ReportApril 25, 2017
Next Earnings ReportJuly 25, 2017
Additionally see analysis of Edwards Lifesciences Correlation with competitors. Please also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..